Nombre del producto |
1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- |
Nombre en inglés |
1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-; 1-Pyrrolidinecarboxylic acid,2,2'- ([1,1'-biphenyl]-4,4'-diyldi-1H- imidazole-5,2-diyl)bis-,1,1'-bis(1,1- dimethylethyl)ester,(2S,2'S)-; (2S,2'S)-di-tert-butyl 2,2'-(4,4'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-iMidazole-4,2-diyl))bis(pyrrolidine-1-carboxylate); Daclatasvir intermediate-4; (2S,2'S)-2,2'-[(1,1'-biphenyl)-4,4'-diyldi-1H-imidazole-5,2-diyl]bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester; 1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)- |
Fórmula molecular |
C36H44N6O4 |
Peso Molecular |
624.34 |
Número de registro CAS |
1007882-23-6 |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|